Brown & Brown, Inc. Announces the Asset Acquisition of Universal Benefit Solutions, L.L.C.
Oct 16, 2017 10:45 am UTC| Business
DAYTONA BEACH, Fla., Oct. 16, 2017 -- J. Scott Penny, Chief Acquisitions Officer of Brown, Inc. (NYSE:BRO), and Brandon Brickweg, the founder of Universal Benefit Solutions, L.L.C. (“UBS”), today announced that Pacific...
ChromaDex to Present at the 2017 BIO Investor Forum
Oct 16, 2017 10:30 am UTC| Business
IRVINE, Calif., Oct. 16, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of science-based, proprietary health and wellness consumer products and ingredient technologies that promote health longevity announced today...
Oct 16, 2017 10:30 am UTC| Business
1.89 g/t Au over 13.7 m within 1.22 g/t Au over 32.0 m1.93 g/t Au over 10.7 m within 0.67 g/t Au over 53.3 m VANCOUVER, British Columbia, Oct. 16, 2017 -- Liberty Gold Inc. (LGD - TSX) ("Liberty Gold" or the...
DNA Polymerase Market to be worth US$ 389.4 Mn by the end of 2027 - Future Market Insights
Oct 16, 2017 10:28 am UTC| Business
Valley Cottage, NY, Oct. 16, 2017 -- Future Market Insights presents a detailed forecast and in-depth insights on the global DNA Polymerase Market in a new report titled ‘DNA Polymerase Market: Global Industry Analysis...
Oct 16, 2017 10:16 am UTC| Business
New York, Oct. 16, 2017 -- In the minimally invasive surgeries, small incisions are made on the body. A laparoscope is inserted through one of the incisions or openings to serve as a guide during the surgery. A...
Leadless Pacing Systems Market to Reach US$ 63.5 Mn by 2025 – Persistence Market Research
Oct 16, 2017 10:11 am UTC| Business
New York, Oct. 16, 2017 -- According to the latest market report published by Persistence Market Research titled ‘Leadless Pacing Systems Market: Global Industry Analysis (2012 – 2016) Forecast (2017 – 2025),’ the...
Oct 16, 2017 10:00 am UTC| Business
Study met primary endpoint (p=0.0033) Significant reduction in cisplatin induced hearing loss without any evidence of tumour protection in patients with Standard Risk Hepatoblastoma (SR-HB)Company plans to pursue...